Literature DB >> 7195677

Verapamil-induced hyperprolactinemia and galactorrhea.

L E Gluskin, B Strasberg, J H Shah.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7195677     DOI: 10.7326/0003-4819-95-1-66

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  14 in total

Review 1.  Medical management of prolactin-secreting pituitary adenomas.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 2.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

Review 4.  A comparative review of the adverse effects of calcium antagonists.

Authors:  H T Dougall; J McLay
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

Review 5.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

6.  Calcium antagonists and endocrine status: lack of effect of oral verapamil on pituitary-testicular and pituitary-thyroid function.

Authors:  C G Semple; J A Thomson; G H Beastall; A R Lorimer
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

Review 7.  Effects of antihypertensive drugs on endocrine function.

Authors:  E P Brass
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

8.  Verapamil-induced "primary" polydipsia.

Authors:  I D Schwartz; D Scagliotti
Journal:  Pediatr Cardiol       Date:  1995 Sep-Oct       Impact factor: 1.655

9.  Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain.

Authors:  F Fadda; G L Gessa; E Mosca; E Stefanini
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

Review 10.  Drugs and prolactin.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.